Chemotherapy in nasopharyngeal carcinoma;La chimiothérapie dans les cancers du cavum

Annales d'Oto-Laryngologie et de Chirurgie Cervico-Faciale

Volumn 123, Issue 2, 2006, Pages 59-64

  M'Rabti, H ^a,b   Sbiti, Y ^a   Afqir, S ^a   Boutayeb, S ^a   Errihani, H ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^b NONE   (Morocco)

Author keywords

Carcinoma; Chemotherapy; Concurrent chemo radiation; Nasopharyngeal

Indexed keywords

EID: 33744923402     PISSN: 0003438X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-438x(06)76643-9     Document Type: Review

References (31)

1. PARKIN DM, WHELAN SL, RAYMOND L, et al. Cancer incidence in five continents. Lyon :IARC press, 1997.
2. VOKES EE, LIEBOWITZ DN. Nasopharyngeal carcinoma. Lancet 1997;350:1087-91.
3. FERLAY J, BRAY F, PISANI P, et al. Cancer incidence, mortality and prevalence wordwide, version 1.0 (IARC Cancer Base N″5). Lyon :IARC Press, 2001.
4. Berrino F, Capocaccia R, Esteve J,. Survival of cancer patients in Europe. The Eurocare-II Study. Lyon :International Agency for Research on cancer. Lyon :IARC press, 1999.
5. KHOURY GG, PATERSON IC. Nasopharyngeal carcinoma :a review of cases treated by radiotherapy and chemotherapy. Clin Radiol. 1987;38:17-20.
6. CVITKOVIC E and the International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (∞N2, M0) undifferentiated nasopharyngeal carcinoma :A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35 :463-9.
7. CHUA DTT, SHAM JST, CHOY D, et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 1998;83:2270-83.
8. AL-SARRAF M, LEBLANC M, GIRI PGS, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer :Phase III randomized Intergroup Study 0099. J Clin Oncol 1998;76:1310-7.
9. JIN-CHING LIN, JIAN-SHENG JAN, CHEN-YI HSU, et al. Phase III Study of Concurrent Chemoradiotherapy versus Radiotherapy alone for advanced nasopharyngeal carcinoma :Positive effect on overall and progression-free survival. J Clin Oncol 2003;21:631-7.
10. DANIEL TT, CHUA, JUN MA, et al. Long term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma :a pooled datd analysis for two phase III trials. J Clin Oncol 2005;23:1118-24.
11. ROSSI A, MOLINARI R, BORACCHI P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer : Results of a 4-year multicenter randomized study. J Clin Oncol 1988;6:1401-10.
12. CHAN ATC, TEO PML, LEUNG TWT, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569-77.
13. MA J, MAI HQ, HONG MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001; 19:1350-7.
14. CHI KH, CHANG YC, GUO WY, et al. A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 2002;52:1238-44.
15. CHAN ATC, TEO PML, NGAN RK, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma :Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 2002;20:2038-44.
16. HAREYAMA M, SAKATA K, SHIRATO H, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 2002;94:2217-23.
17. DECKER DA, DRELICHMAN A, AL-SARRAF M, et al. Chemotherapy for nasopharyngeal carcinoma. A ten years experience. Cancer 1983;52:602-5.
18. BOUSSEN H, CVITKOVIC E, WENDLING JL, et al. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. J Clin Oncol 1991 ;9:1675-81. http://www.jco.org/ cgi/ijlink?linkType=ABST&journalCode=jco&resid=9/9/1675
19. GEBBIA V, ZERILLO G, RESTIVO G, et al. Chemotherapeutic treatment of recurrent and or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br J Cancer 1993;68:191-4.
20. AU E, ANG PT. A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma. Ann Oncol. 1994;5:87-9.
21. AZLI N, FANDI A, BACHOUCHI M, et al. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer J Sci Am 1995;1:222-9.
22. STEIN ME, RUFF P, WEAVING A, et al. A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa. Am J Clin Oncol 1996;19:386-8.
23. HASBINI A, MAHJOUBI R, FANDI A, et al. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type. Ann Oncol 1999;10:421-5.
24. TAAMMA A, FANDI A, AZLI N, et al. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer 1999;86:1101-8.
25. FOO KF, TAN EH, LEONG SS, et al. Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferenciated type. Ann Oncol. 2002;13:150-6.
26. AU E, TAN EH, ANG PT. Activity of paclitaxel by three hour infusion in Asian patients with metastatic undifferenciated nasopharyngeal cancer. Ann Oncol 1998;9:327-9.
27. CHUA DT, SHAM JS, Au GK. A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Oral Oncol 2003;39:361-6.
28. MA BB, TANNOCK IF, POND GR, et al. Chemotherapy with gemcitabine- containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma. Cancer 2002;95:2516-23.
29. YEO W, LEUNG TW, CHAN AT, et al. A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer 1998;34:2027-31.
30. MC CARTHY JS, TANNOCK IF, DEGENDORFER P et al. A phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. Oral Oncol 2002;38:686-90.
31. NGAN RK, YIU HH, LAU WH, et al. Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma :report of a phase II study. Ann Oncol 2002;13:1252-8.